![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
M&A Revival In The Biopharmaceutical Sector Back On Track
It is worth noting that the biopharmaceutical sector has gone on to experience a revival...
Biopharma & Healthcare In Asia-Pacific – Leveraging Ties
In the last five years, there have been various local governments in the Asia-Pacific region...
CDMO-Biotech Collab Diminish Business Risk In Drug Creation
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of...
Cryoport, CGT Catapult Partner on Cell and Gene Therapies
Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing...
Biopharma Enhancing Visibility in Connected Supply Chain
The biopharmaceutical industry, with a market value exceeding $350 billion, stands as a cornerstone of...
Cell And Gene Therapy Market Soars, Forecasted At $82.24B
The global cell and gene therapy market has witnessed remarkable growth, with a market size...
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for...
Key Steps For Biopharma Startups Getting Ready For EU HTA
What is the Joint European HTA?
Navigating pricing and reimbursement in the European Union (EU) can...
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal...
Overcoming Challenges In Biopharma Novel Drug Manufacturing
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology,...